X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1202) 1202
Publication (77) 77
Newsletter (47) 47
Book Review (33) 33
Book Chapter (22) 22
Book / eBook (5) 5
Conference Proceeding (5) 5
Magazine Article (5) 5
Newspaper Article (2) 2
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (893) 893
male (766) 766
hypogonadism (649) 649
index medicus (583) 583
testosterone (499) 499
adult (332) 332
endocrinology & metabolism (303) 303
middle aged (299) 299
aged (279) 279
female (271) 271
risk factors (260) 260
testosterone - blood (230) 230
hypogonadism - drug therapy (226) 226
testosterone - therapeutic use (211) 211
osteoporosis (197) 197
urology & nephrology (193) 193
men (191) 191
hypogonadism - complications (181) 181
androgens (168) 168
hormone replacement therapy (166) 166
late-onset hypogonadism (164) 164
metabolic syndrome (149) 149
adolescent (146) 146
research (137) 137
erectile dysfunction (136) 136
older men (134) 134
bone-mineral density (133) 133
animals (117) 117
hypogonadism - blood (111) 111
obesity (108) 108
prevalence (106) 106
health aspects (105) 105
testosterone - deficiency (105) 105
medicine & public health (104) 104
bone density (102) 102
care and treatment (100) 100
hypogonadism - etiology (99) 99
diabetes (97) 97
aging (96) 96
hypogonadism - diagnosis (96) 96
prostate cancer (96) 96
hypogonadotropic hypogonadism (89) 89
middle-aged men (89) 89
osteoporosis - etiology (88) 88
analysis (86) 86
therapy (86) 86
hormones (85) 85
hypogonadism - physiopathology (85) 85
medicine, general & internal (83) 83
aged, 80 and over (82) 82
serum testosterone (80) 80
women (80) 80
body mass index (79) 79
diagnosis (78) 78
replacement therapy (78) 78
young adult (77) 77
physiological aspects (76) 76
endocrinology (75) 75
child (74) 74
androgens - therapeutic use (72) 72
insulin-resistance (72) 72
androgen deficiency (71) 71
body-composition (69) 69
andrology (68) 68
elderly-men (67) 67
hormone-binding globulin (67) 67
testosterone - administration & dosage (67) 67
cancer (66) 66
hypogonadism - epidemiology (65) 65
mortality (65) 65
risk (65) 65
treatment outcome (64) 64
testosterone replacement therapy (62) 62
metabolism (61) 61
prevention (61) 61
age (60) 60
complications and side effects (59) 59
abridged index medicus (58) 58
prostate-cancer (57) 57
cross-sectional studies (56) 56
hypogonadal men (55) 55
insulin resistance (55) 55
internal medicine (55) 55
obstetrics & gynecology (54) 54
retrospective studies (54) 54
testosterone - adverse effects (54) 54
type 2 diabetes (54) 54
bone mineral density (53) 53
density (51) 51
aging - physiology (50) 50
low serum testosterone (50) 50
bone density - drug effects (49) 49
quality-of-life (49) 49
urology (49) 49
cardiovascular disease (48) 48
case-control studies (48) 48
erectile dysfunction - etiology (48) 48
hormone replacement therapy - methods (48) 48
risk-factors (48) 48
osteoporosis - prevention & control (47) 47
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1193) 1193
German (20) 20
French (17) 17
Spanish (13) 13
Russian (12) 12
Italian (10) 10
Japanese (5) 5
Chinese (2) 2
Polish (2) 2
Portuguese (2) 2
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2012, Volume 62, Issue 2, pp. 273 - 286
Journal Article
Osteoporosis International, ISSN 0937-941X, 4/2012, Volume 23, Issue 4, pp. 1255 - 1265
Pain medication has been associated with fractures. We found higher weight in paracetamol and non-steroidal anti-inflammatory drugs (NSAID) users and lower... 
Paracetamol | Medicine & Public Health | Bone mineral | Orthopedics | Gynecology | Rheumatology | Opioid | Fracture | Acetylsalicylic acid | Endocrinology | Non-steroidal anti-inflammatory drugs | VITAMIN-D | FALLS | METAANALYSIS | RANDOMIZED CONTROLLED-TRIAL | ASPIRIN | WOMEN | THERAPY | PROSTAGLANDINS | ENDOCRINOLOGY & METABOLISM | ROFECOXIB | HYPOGONADISM | Acetaminophen - adverse effects | Risk Assessment - methods | Follow-Up Studies | Humans | Middle Aged | Acetaminophen - administration & dosage | Analgesics, Non-Narcotic - pharmacology | Analgesics, Opioid - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Analgesics, Opioid - adverse effects | Acetaminophen - pharmacology | Aspirin - adverse effects | Analgesics, Non-Narcotic - adverse effects | Female | Aspirin - pharmacology | Osteoporotic Fractures - epidemiology | Osteoporotic Fractures - physiopathology | Analgesics, Non-Narcotic - administration & dosage | Bone Density - drug effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Osteoporotic Fractures - chemically induced | Analgesics, Opioid - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Denmark - epidemiology | Anthropometry - methods | Complications and side effects | Aspirin | Fractures | Dosage and administration | Research | Nonsteroidal anti-inflammatory drugs | Risk factors | Bone density | Drug therapy | Pain management | Dual energy X-ray absorptiometry | Spine | Hormones | Hip | Nonsteroidal antiinflammatory drugs | Opioid receptors (type delta) | Osteoporosis | Forearm | Pain | Vitamin D | Risk assessment | Opioids | Bone mineral density | paracetamol
Journal Article
American Journal of Hematology, ISSN 0361-8609, 12/2014, Volume 89, Issue 12, pp. 1102 - 1106
Iron overload in β‐thalassemia major (TM) typically results in iron‐induced cardiomyopathy, liver disease, and endocrine complications. We examined the... 
IMPACT | TRANSFUSIONAL IRON OVERLOAD | MRI | MASS | REPLACEMENT THERAPY | IMPROVEMENT | COMPLICATIONS | PREVALENCE | HEMATOLOGY | HYPOGONADISM | NORTH-AMERICA | Diabetes Mellitus - pathology | Hypothyroidism - pathology | Hypothyroidism - metabolism | Benzoates - therapeutic use | Humans | Middle Aged | Child, Preschool | Male | Puberty, Delayed - metabolism | Iron Overload - etiology | Osteoporosis - metabolism | Hypogonadism - metabolism | Bone and Bones - metabolism | Diphosphonates - therapeutic use | Child | Triazoles - therapeutic use | Iron Chelating Agents - therapeutic use | Hypoparathyroidism - metabolism | beta-Thalassemia - drug therapy | Puberty, Delayed - pathology | Diabetes Mellitus - prevention & control | Osteoporosis - pathology | Adolescent | beta-Thalassemia - metabolism | Hypogonadism - etiology | beta-Thalassemia - pathology | Bone and Bones - pathology | Iron Overload - drug therapy | Calcium - administration & dosage | Chelation Therapy | beta-Thalassemia - complications | Hypoparathyroidism - pathology | Hypoparathyroidism - prevention & control | Iron Overload - pathology | Osteoporosis - etiology | Bone and Bones - drug effects | Hypogonadism - prevention & control | Iron Overload - metabolism | Puberty, Delayed - etiology | Adult | Diabetes Mellitus - etiology | Female | Vitamin D - administration & dosage | Retrospective Studies | Hypothyroidism - prevention & control | Hypogonadism - pathology | Bone Density | Osteoporosis - prevention & control | Diabetes Mellitus - metabolism | Hypothyroidism - etiology | Puberty, Delayed - prevention & control | Hypoparathyroidism - etiology
Journal Article
Pakistan Journal of Pharmaceutical Sciences, ISSN 1011-601X, 03/2017, Volume 30, Issue 2, p. 375
Raphanus sativus seeds are used as condiment and to treat hypogonadism, various ailments of liver and kidneys. The aim of this study was to evaluate the... 
Prevention | Usage | Radishes | Health aspects | Hypogonadism | Daikon | Materia medica, Vegetable | Plant extracts
Journal Article
Endocrine Journal, ISSN 0918-8959, 2017, Volume 64, Issue 10, pp. 933 - 946
Hormonal alterations with aging contribute to the pathogenesis of several diseases. Androgens mediate their effects predominantly through binding to the... 
Sarcopenia | Osteoporosis | Prostate cancer | Androgen receptor | Dementia | METABOLIC SYNDROME | LOW TESTOSTERONE | MUSCLE DEVELOPMENT | MALE-MICE | COGNITIVE FUNCTION | DEPRIVATION THERAPY | COMPLEMENTARY-DNA | PROSTATE-CANCER | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | INCREASED SURVIVAL | Neoplasms - metabolism | Prostatic Neoplasms - metabolism | Humans | Receptors, Androgen - metabolism | Male | Neoplasms - prevention & control | Risk | Dementia - epidemiology | Hormone Replacement Therapy - adverse effects | Chronic Disease - prevention & control | Dementia - metabolism | Osteoporosis - metabolism | Aging | Androgens - therapeutic use | Receptors, Androgen - chemistry | Epigenesis, Genetic - drug effects | Androgens - adverse effects | Prostatic Neoplasms - prevention & control | Sarcopenia - metabolism | Osteoporosis - epidemiology | Androgens - secretion | Osteoporosis - prevention & control | Gene Expression Regulation, Developmental - drug effects | Chronic Disease - epidemiology | Sarcopenia - epidemiology | Animals | Receptors, Androgen - genetics | Models, Biological | Sarcopenia - prevention & control | Quality of Life | Androgens - metabolism | Dementia - prevention & control | Neoplasms - epidemiology | Animal models | Gene expression | Patients | Hypogonadism | Quality of life | Androgens | Dementia disorders | Epigenetics | Hormone replacement therapy | Reproductive system | Cardiovascular diseases | Prostate
Journal Article
Pakistan Journal of Pharmaceutical Sciences, ISSN 1011-601X, 03/2017, Volume 30, Issue 2, pp. 375 - 380
Raphanus sativus seeds are used as condiment and to treat hypogonadism, various ailments of liver and kidneys. The aim of this study was to evaluate the... 
Lipid peroxidation | Antioxidant | Raphanus sativus L. carbon tetrachloride | Hypogonadism | CELLS | antioxidant | hypogonadism | ASSAY | GLUTATHIONE | ENZYMES | RADISH | PHARMACOLOGY & PHARMACY | CARBON-TETRACHLORIDE | lipid peroxidation | DAMAGE
Journal Article
Evidence-based Complementary and Alternative Medicine, ISSN 1741-427X, 2012, Volume 2012, pp. 125761 - 9
Journal Article
Journal Article
Journal Article
Child and Adolescent Psychiatric Clinics of North America, ISSN 1056-4993, 07/2007, Volume 16, Issue 3, pp. 695 - 708
In this article the authors discuss the genetic, medical, and endocrinologic issues of Prader-Willi syndrome and their treatment. The authors also present the... 
GROWTH-HORMONE TREATMENT | AUTISM | GENOTYPE | PSYCHIATRY | ADULTS | DISORDERS | TOPIRAMATE | PEOPLE | BODY-COMPOSITION | COGNITION | HYPOGONADISM | Human Growth Hormone - therapeutic use | Child Behavior Disorders - prevention & control | Prader-Willi Syndrome - prevention & control | Child | Humans | Prader-Willi Syndrome - drug therapy
Journal Article
Journal Article